ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
0.9886
-0.0016 (-0.16%)
Apr 25, 2025, 12:22 PM EDT - Market open
PROK's stock price has decreased by -60.86% in the past year and price targets may not have had time to catch up.
ProKidney Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$5.00
Upside
+405.77%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 30, 2024 |
Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +506.92% | Sep 10, 2024 |
B of A Securities | B of A Securities | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +203.46% | Sep 4, 2024 |
Jefferies | Jefferies | Strong Buy Maintains $15 → $6 | Strong Buy | Maintains | $15 → $6 | +506.92% | Jun 10, 2024 |
B of A Securities | B of A Securities | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +304.61% | May 29, 2024 |
Morgan Stanley | Morgan Stanley | Hold Initiates $3 | Hold | Initiates | $3 | +203.46% | Mar 7, 2024 |
B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $8 → $2 | Strong Buy → Hold | Downgrades | $8 → $2 | +102.31% | Jan 2, 2024 |
BTIG | BTIG | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +1,518.45% | Jul 25, 2023 |
Jefferies | Jefferies | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +1,417.30% | Dec 21, 2022 |
Morgan Stanley | Morgan Stanley | Hold Initiates $13 | Hold | Initiates | $13 | +1,214.99% | Nov 10, 2022 |
UBS | UBS | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +1,720.76% | Oct 18, 2022 |
Citigroup | Citigroup | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +1,518.45% | Oct 14, 2022 |
Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 2, 2022 |